Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine ...

[8] Respiratory syncytial virus (RSV) is a highly contagious and potentially serious virus that can lead to respiratory ...

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

Coughing, sneezing, and high temperature are common signs of a cold. While these may look harmless, they can also be symptoms ...

A study has highlighted ways to reduce RSV infections - including a vaccine programme which could reduce antibiotic ...

The full-time GP and author said there's a 'quadruple-demic' - referring to four viruses currently circulating: respiratory ...

Public health officials reiterated the importance of vaccines after seeing a rise in circulating levels of respiratory syncytial virus (RSV).

As flu and COVID season begins to hit New Mexico in force, health officials are encouraging people to get their vaccinations ...

Rapid antigen-based testing was quickly embraced for its ease of use and speed; results are available within an unprecedented 30 min, potentially at the point of care, and without the requirement ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

While Moderna’s Spikevax beat Wall Street estimates in the third quarter, William Blair analyst Myles Minter in a Thursday ...